NYSE:BIO.B Bio-Rad Laboratories - BIO.B News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $464.10 +72.94 (+18.65%) (As of 03/20/2023 02:47 PM ET) Add Compare Share Share Today's Range$464.10▼$464.1050-Day Range$404.66▼$404.6652-Week Range$355.36▼$750.16Volume235 shsAverage Volume429 shsMarket Capitalization$13.74 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address BIO.B Media Mentions By Week BIO.B Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO.B News Sentiment▼0.000.35▲Average Medical News Sentiment BIO.B News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO.B Articles This Week▼00▲BIO.B Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Zimmer Biomet Holdings (ZBH)markets.businessinsider.com - March 9 at 10:18 AMBio-Rad (BIO) Global Expansion Strong, FX Woe Dents Growthmsn.com - March 9 at 10:18 AMBio-Rad Laboratories (BIO) Upgraded From Hold to Buythestreet.com - January 15 at 8:24 PMGT Molecular Releases Respiratory Panels and Poliovirus Typing Assays for Leading PCR Platformsmarkets.businessinsider.com - December 20 at 8:15 PMBio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Downmsn.com - October 28 at 9:19 PMBio-Rad Laboratories (BIO) Surpasses Q3 Earnings Estimatesmsn.com - October 27 at 7:53 PMBio-Rad Laboratories, Qiagen Mull Merger Of Equalsmsn.com - October 11 at 8:34 AMEast Bay life sciences company reportedly in talks with Qiagen in $10 billion dealbizjournals.com - October 10 at 5:31 PMThe Global Flow Cytometry Market size is expected to reach $7.7 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast periodbenzinga.com - September 29 at 4:33 PMIs Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?finance.yahoo.com - June 20 at 7:02 AMBio-Rad Laboratories Inc. Class Athestreet.com - June 13 at 3:14 AMThe 4.8% return this week takes Bio-Rad Laboratories' (NYSE:BIO) shareholders five-year gains to 140%finance.yahoo.com - May 28 at 10:15 AMWall Street Analysts Believe Bio-Rad (BIO) Could Rally 53%: Here's is How to Tradefinance.yahoo.com - May 25 at 12:04 PMWorldwide Mononucleosis Diagnostic Industry to 2027 - Rising Health Awareness and Knowledge Among Patients is Driving Growth - ResearchAndMarkets.comapnews.com - April 25 at 3:21 PMPolymerase Chain Reaction Market to Advance at CAGR of 6.4% During 2021–2028, Says TMRsg.finance.yahoo.com - April 17 at 1:05 PMEarnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Declinenasdaq.com - February 3 at 5:49 PMOutlook on the Cell Isolation Global Market to 2026 - by Technique, Cell Type, Product, Application, End-use and Region - ResearchAndMarkets.comuk.finance.yahoo.com - December 15 at 3:23 PMHedge Funds Are Selling Bio-Rad Laboratories, Inc. (BIO)finance.yahoo.com - December 8 at 12:56 PMBio Rad (BIO) Grows Internationally on New Product Launchesfinance.yahoo.com - November 25 at 12:38 PMOutlook on the Cell Sorting Global Market to 2026...benzinga.com - November 10 at 11:14 PMBio-Rad Laboratories Inc. Cl Bbarrons.com - November 5 at 7:35 PMBio-Rad Laboratories (BIO) Is Up 0.05% in One Week: What You Should Knowmsn.com - September 14 at 3:18 PMBio-Rad Laboratories (BIO)forbes.com - August 25 at 8:22 PMQuidel Corp.barrons.com - December 5 at 1:51 AMBio-Rad Laboratories, Inc. Class B Common Stock (BIO.B)nasdaq.com - October 19 at 8:54 PMBio-Rad Laboratories Inc. Buymarkets.businessinsider.com - August 18 at 9:16 AMBio Rad Laboratories Incmarkets.ft.com - November 21 at 9:32 PMBio-Rad Laboratories Inc (BIO) (BIO-B) Q2 2019 Earnings Call Transcriptwww.fool.com - August 1 at 9:09 PMBio-Rad Laboratories, Inc. Class B Common Stock Real Time Stock Quoteswww.nasdaq.com - June 17 at 3:57 PM Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NYSE:BIO.B) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.